KBFS
ARKG icon

Kohmann Bosshard Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$467 – 235
2025
Q4 		$467 Buy
+17
New +$510 ﹤0.01% 1001
2025
Q1 		– Sell
-70
Closed -$1.65K – 319
2024
Q4 		$1.65K Buy
+70
New +$1.72K ﹤0.01% 580

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Kohmann Bosshard Financial Services's ARKG Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 17 shares — an estimated $467 sold.

Kohmann Bosshard Financial Services first reported a position in ARKG in Q4 2024 and held it in 2 quarters. The position peaked at $1.65K in Q4 2024. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 17 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $467.
  • Kohmann Bosshard Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's ARK Genomic Revolution ETF position peaked at $1.65K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.